Sparsentan
AC22084
Phase 2 small_molecule active
Quick answer
Sparsentan for ANCA Associated Vasculitis is a Phase 2 program (small_molecule) at Travere Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Travere Therapeutics
- Indication
- ANCA Associated Vasculitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active